close

Innovation in our DNA

My name is Beatrice, I lead the Health Policy Centre, an initiative launched by Janssen to answer a question: What if there was a way to respond to the bold challenges faced by the healthcare world with new innovative ideas?

For 130 years, Johnson & Johnson has helped improve health around the world and our starting point has always been the patient as we race against time to address unmet needs.

Then in 2012, we created the Health Policy Centre in to increase collaboration with public and private healthcare partners, to challenge perspectives, and to work together to stimulate policymakers’ awareness of the most serious health issues facing society. By fostering close partnerships and alliances with other industry players, the academic world, and public health organisations, we are continually exploring ways of collaborating more broadly and efficiently in order to secure better patient outcomes.

This is an essential first step in finding new solutions to combat diseases that have a major impact on society, including diabetes, schizophrenia, infectious diseases, cancers, depression, and Alzheimer’s disease.

Europe’s population is getting older and living longer. While the former is seen by some as worrying, the latter is undoubtedly one of the greatest achievements of our healthcare model. More than ever it is clear that we cannot work in isolation if we are to find solutions to the challenges before us. Innovation in healthcare is more than developing medicines that will transform the lives of patients. It’s about providing a better quality of service where the patient is at the heart of all decisions and improving access for everyone, all within a responsible business environment. Those who make these decisions are a key target for our work, including through initiatives like the Health Policy Centre, and so, they are also included in stimulating discussions and in access to the latest data and viewpoints available. This mutual openness is critical for building collaborative solutions.

I won’t rest until we find common ground for reshaping healthcare to meet the demands of tomorrow’s world.

Biography

With 32 years of specialised healthcare business experience, Beatrice Tardieu is currently Senior Director in Janssen’s EMEA Communication and Public Affairs team. Among other tasks, she leads the work on the Health Policy Centre, a cross-functional platform that provides the latest information and data on specific therapeutic areas as well as the broader healthcare sector. Equipped with a professional doctorate degree in pharmacy and an MBA from the ESSEC Business School, Beatrice is centrally placed for working on building awareness on healthcare policy that reaches a wide variety of audiences and helps to shape the decisions taken today that will shape the healthcare systems of tomorrow. Focusing on the provision of comparable data, publication of white papers, and the creation of specific activities to engage across teams, across specialisations, and across stakeholder groups, Beatrice provides an integrated approach in the healthcare business that balances the interests of stakeholder, their engagement and needs, as well as the company objectives, in a collaborative, transparent, and engaging way.